KRAS and non-small cell lung carcinoma: In Wang H’s study, mutations of EGFR, KRAS, and ALK are highly concordant between primary NSCLC and matched brain metastases, whereas discordance of PI3K signaling suggested the unique genomic evolution and oncogenic mechanisms of brain metastasis (32).